Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.7121
-0.0312 (-4.20%)
At close: Feb 20, 2026, 4:00 PM EST
0.7010
-0.0111 (-1.56%)
After-hours: Feb 20, 2026, 7:29 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Clinical Laboratory Goods
39.37M42.29M46.04M-84.28M
Clinical Laboratory Goods Growth
-6.90%-8.14%---
Clinical Laboratory Services
4.75M5.45M7.27M-8.49M
Clinical Laboratory Services Growth
-12.89%-25.01%---
Point-Of-Care Products
17.43M9.09M9.21M-9.22M
Point-Of-Care Products Growth
91.76%-1.32%---
Total
61.56M56.83M62.52M-101.98M
Total Growth
8.31%-9.10%--12.77%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Americas
61.61M66.85M76.62M116.31M136.99M
Americas Growth
-7.84%-12.75%-34.12%-15.10%32.22%
Rest of World – Ireland
20.47M12.72M25.10M28.23M25.39M
Rest of World – Ireland Growth
60.89%-49.32%-11.10%11.21%-9.39%
Eliminations
-20.52M-22.74M-26.94M-51.58M-60.40M
Total
61.56M56.83M74.78M92.97M101.98M
Total Growth
8.31%-24.00%-19.56%-8.84%12.77%
Source: S&P Global Market Intelligence.